product summary
Loading...
company name :
StressMarq Biosciences
product type :
protein
product name :
Alpha Synuclein Pre-formed Fibrils (Type 1)
catalog :
SPR-324
quantity :
100 µg
citations: 16
Reference
Zheng Q, Gao Y, Han M, Wang Y, Liu H, Cao G, et al. Inhibiting Immune Crosstalk by Modulation of the Intracellular Function and Extracellular Environment of Diseased Microglia to Boost Parkinson's Disease Therapy. ACS Nano. 2025;19:19177-19197 pubmed publisher
Filippini A, Carini G, Barbon A, Gennarelli M, Russo I. Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils. Acta Neuropathol Commun. 2025;13:98 pubmed publisher
Desai A, Zupancic J, Trzeciakiewicz H, Gerson J, DuBois K, Skinner M, et al. Facile generation of drug-like conformational antibodies specific for amyloid fibrils. Nat Chem Biol. 2025;21:916-925 pubmed publisher
Maruf A, Gerasymchuk D, Hlushchuk I, Er S, Milewska M, Chmielarz P, et al. Trehalose-releasing nanogels reduce α-synuclein-induced Lewy body-like inclusions in primary mouse hippocampal neurons. J Mater Chem B. 2025;13:5845-5857 pubmed publisher
Trepczyk K, Er S, Hlushchuk I, Airavaara M, Alwani A, Maziarz K, et al. Peptidomimetics Activating the Proteasome: A New Perspective for Parkinson's Treatment. J Med Chem. 2025;68:8967-8979 pubmed publisher
Cao B, Chen X, Li Y, Zhou T, Chen N, Guo Y, et al. PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson's disease. NPJ Parkinsons Dis. 2024;10:146 pubmed publisher
Parmasad J, Ricke K, Nguyen B, Stykel M, Buchner Duby B, Bruce A, et al. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. Cell Death Dis. 2024;15:246 pubmed publisher
Desai A, Zupancic J, Trzeciakiewicz H, Gerson J, DuBois K, Skinner M, et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv. 2023;: pubmed publisher
Lee J, Sung K, Bae E, Yoon D, Kim D, Lee J, et al. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology. Mol Neurodegener. 2023;18:41 pubmed publisher
Ghosh A, Verma D, Cabrera G, Ofori K, Hernandez Quijada K, Kim J, et al. A Novel NOX Inhibitor Treatment Attenuates Parkinson's Disease-Related Pathology in Mouse Models. Int J Mol Sci. 2022;23: pubmed publisher
Hlushchuk I, Barut J, Airavaara M, Luk K, Domanskyi A, Chmielarz P. Cell Culture Media, Unlike the Presence of Insulin, Affect α-Synuclein Aggregation in Dopaminergic Neurons. Biomolecules. 2022;12: pubmed publisher
Holland D, Prebble D, Er S, Hayton J, Robertson L, Avery V, et al. α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian Synoicum prunum. J Nat Prod. 2022;85:441-452 pubmed publisher
Bhatia T, Clark R, Needham P, Miner K, Jamenis A, Eckhoff E, et al. Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy. Neurotherapeutics. 2021;: pubmed publisher
Verma D, Seo B, Ghosh A, Ma S, Hernandez Quijada K, Andersen J, et al. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models. Cells. 2021;10: pubmed publisher
Hlushchuk I, Ruskoaho H, Domanskyi A, Airavaara M, Välimäki M. Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation. ACS Chem Neurosci. 2021;12:2273-2279 pubmed publisher
Verma D, Ghosh A, Ruggiero L, Cartier E, Janezic E, Williams D, et al. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models. Eneuro. 2020;7: pubmed publisher
product information
Catalog No :
SPR-324
Product Name :
Alpha Synuclein Pre-formed Fibrils (Type 1)
Description :
Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)
Size :
100 µg
Research Area(s) :
Neuroscience Neurodegeneration Alzheimer's Disease Tangles & Tau Neuroscience Neurodegeneration Parkinson's Disease Synuclein Neuroscience Neurodegeneration Multiple System Atrophy
Alternative Name(s) :
Alpha synuclein PFFs, Alpha synuclein PFF, Alpha synuclein aggregates, Alpha synuclein protein aggregates, Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson's disease familial 1 Protein
Category :
Protein
Nature :
Recombinant
Accession Number :
NP_001035916.1
Swiss-Prot :
O55042
Applications :
WB SDS-PAGE In vivo assay In vitro assay
Species :
Mouse
Expression System :
E. coli
Protein Length :
Full Length
Amino Acid Sequence :
MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVTTVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGNIAA ATGFVKKDQM GKGEEGYPQE GILEDMPVDP GSEAYEMPSE EGYQDYEPEA
Purity :
>95%
Protein Size :
~14.46 kDa
Conjugate :
No tag
Cellular Localization :
Cytoplasm Membrane Nucleus
company information
StressMarq Biosciences
PO Box 55036 CADBORO BAY
3825 Cadboro Bay Road
Victoria BC V8N 4G0
info@stressmarq.com
http://www.stressmarq.com
1-250-294-9065
headquarters: canada
StressMarq Biosciences Inc. is a bioreagents company producing high-quality antibodies, antibody conjugates, proteins, assay kits, and small molecules for the life sciences.
With over 17,000 products, we offer a wide range of products for scientists in cancer, neuroscience, epigenetics, cell signalling, and cellular stress research areas.
Based in Victoria, BC, with a small but dedicated group of scientists, StressMarq provides highly-validated products that are sold with our quality guarantee, and supported by our years of scientific expertise. Our products are available in over 50 countries through our extensive distributor network.
StressMarq draws on scientific excellence from around the globe. We strive to partner with academic or for-profit institutions through licensing agreements to bring cutting-edge research tools to the scientific community.